Registry of Subjects at Risk of Pancreatic Cancer
Recruiting
Observational Study
Familial Pancreatic Cancer
BRCA1 Mutation
BRCA2 Mutation
Lynch Syndrome
FAMMM - Familial Atypical Mole Malignant Melanoma Syndrome
Hereditary Pancreatitis
Peutz-Jeghers Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Associazione Italiana per lo Studio del Pancreas · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria to enter the registry:
* individuals with at least two relatives suffering from pancreatic cancer, with at least 1 first-degree and until the third-degree
* subjects with known genetic mutation of BRCA2, BRCA1, p16, PALB2 with at least 1 first- or 2nd-degree relative suffering fr…
Contacts